Stereotactic body radiotherapy may improve control of localised kidney cancer

A recent study published in The Journal of Urology this month suggests that stereotactic body radiotherapy (SBRT) may be a safe and effective therapeutic option that could control the growth of localised, small numbers of metastases (oligometastatic) in people with advanced renal cell carcinoma (RCC). Fifty-eight RCC patients, who had undergone surgery and had a maximum […]

read more

Robotic partial nephrectomy versus open or laparoscopic partial nephrecotmy

A recent literature review and meta-analysis of worldwide data, published in Journal of Urology, reports that undergoing partial nephrectomy using a robotic surgical approach resulted in outcomes that were mostly superior, or at least as good as, those seen with open or laparoscopic partial nephrectomy. The analysis included data from 33 studies including 20,282 patients. Robotic partial nephrectomy […]

read more

Robotic partial nephrectomy found to be mostly superior to other surgeries

A recent review and meta-analysis by researchers from the University of Southern California Keck School of Medicine in Los Angeles, USA, has shown that robotic partial nephrectomy results in mostly better outcomes than either open or laparoscopic partial nephrectomy. The study was published in the Journal of Urology this month. Robotic partial nephrectomy was associated […]

read more

Should the primary kidney tumour be treated in metastatic disease?

Dr Gennady Bratslavsky gave a presentation at a urology symposium in Israel last week discussing the question of whether the primary tumour should be treated in metastatic renal cell carcinoma (RCC). The outline of his presentation included: Current guidelines for metastatic RCC The rational behind cytoreductive nephrectomy (CN) Historical evidence supporting current guidelines A discussion […]

read more

Ablation versus surgery for early stage kidney tumours

A recent paper, published in Annals of Internal Medicine, suggests that percutaneous ablation using heat or cold may result in similar outcomes to those of radical nephrectomy in preselected older patients with early stage renal cell carcinoma (T1a RCC). Percutaneous ablation also results in less long-term renal insufficiency and fewer surgical complications. When compared to […]

read more

An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma

The International Kidney Cancer Coalition (IKCC), of which KCSN is a member, together with the German Cancer Society working group on renal tumours convened a meeting of global experts to review current treatment strategies for bone metastases from renal cell carcinoma (RCC) with the aim to improve the management and outcomes of RCC patients. The […]

read more

Stereotactic radiotherapy for the treatment of metastatic renal cell carcinoma

Results from a recent retrospective study from France, published in the journal Oncology, have shown that stereotactic radiotherapy is safe and effective for metastatic renal cell carcinoma (RCC) patients with metastases in one or two other parts of the body (oligometastatic or oligoprogressive). Stereotactic radiotherapy may also delay the start or change of systemic (drug) therapy. […]

read more

The role of cytoreductive nephrectomy in elderly patients with metastatic kidney cancer

The role of cytoreductive nephrectomy for metastatic renal cell cancer (RCC) is not clearly understood, particularly since the advent of targeted therapies. Data are conflicting, and the use of cytoreductive nephrectomy in the elderly people with metastatic RCC is not well defined. A recent study compared survival between patients with metastatic RCC who underwent cytoreductive […]

read more

Surgery improves survival in metastatic kidney cancer

Researchers from the University of Washington Medical Center in Seattle have published a study showing that cytoreductive nephrectomy (CN) (removal of the kidney containing the tumour) is associated with improved overall survival compared with systemic therapy (without nephrectomy) in people with metastatic renal cell carcinoma (mRCC). The study was published in the Urology journal. 537 mRCC patients were studied […]

read more

Outcomes after cryoablation versus nephrectomy

Percutaneous cryoablation (cryotherapy) is emerging as an alternative to partial nephrectomy (PN) for the removal of small, single kidney tumours while conserving kidney function (nephron-sparing). A new study provides support for cryotherapy, finding no significant differences in the risk for complications, kidney function, and cancer control outcomes compared with partial nephrectomy. The investigators suggested that […]

read more
Showing 61 to 70 of 70 results
  TOP